Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :781
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4814    
    Printed150    
    Emailed1    
    PDF Downloaded421    
    Comments [Add]    
    Cited by others 4    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2006  |  Volume : 43  |  Issue : 3  |  Page : 122-126

Study of the RET gene and his implication in thyroid cancer: Morocco case family


1 Laboratoire de Physiologie et Pharmacologie "UFR Environnement et Santé" FST, Mohammedia, Université Hassan II, Maroc, Morocco
2 Service de Médecine Nucléaire, CHU Ibn Rochd, Faculté de Médecine et de Pharmacie, Université HASSAN II, Maroc, Morocco
3 Laboratoire de Microbiologie et Biologie Moléculaire, Institut Pasteur du Maroc, Maroc, Morocco
4 Laboratoire d'Hormonologie et Marqueurs tumoraux, Institut Pasteur du Maroc, Maroc, Morocco
5 Laboratoire de Biochimie, Environnement et Agroalimentaire" UFR Environnement et Santé" FST, Mohammedia, Université Hassan II, Maroc, Morocco

Correspondence Address:
A Ainahi
Laboratoire de Physiologie et Pharmacologie "UFR Environnement et Santé" FST, Mohammedia, Université Hassan II, Maroc
Morocco
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0019-509X.27934

Rights and Permissions

BACKGROUND: Multiple endocrine neoplasia type 2A (MEN 2A) is an autosomal dominant inherited cancer syndrome that affects multiple tissues derived from the neural crest. Inheritance of MTC is related to the presence of specific mutations in the RET proto-oncogene. Almost all mutations in MEN 2A involve one of the cysteines in the extracellular domain of the RET receptor. AIMS: The objective of the present study was the biochemical and molecular characterization of the first Moroccan clinically established MEN 2A patient and at-risk family members. SETTINGS AND DESIGN: This is a study on a family presented with MTC referred to our institute in 2004. MATERIALS AND METHODS: Peripheral blood leukocyte DNA samples were isolated and amplified by polymerase chain reaction followed by restriction enzyme analysis and DNA sequencing. RESULTS: We identified a heterozygous germ line missense mutation at codon 634 of exon 11 in the RET gene that causes a cysteine to arginine amino acid substitution in the DNA of the proband; this mutation was not found in the DNA of the parents or relatives. CONCLUSIONS: The detection of mutated MEN 2A gene carriers enables us to differentiate high-risk members from those who bear the wild-type gene. Occasionally, application of RET proto-oncogene testing may lead to the detection of unexpected de novo mutation that could be transmitted to children.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow